Another, A Few Good Device for End Stage Heart Failure

DOI QR Code

Jooyeon Lee (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine) ;
Jaewon Oh (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine) ;
Seok-Min Kang (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine)

Vis A, Arfaee M, Khambati H, et al. The ongoing quest for the first total artificial heart as destination therapy. Nat Rev Cardiol 2022;19:813-28. https://doi.org/10.1038/s41569-022-00723-8
Kuroda T, Miyagi C, Fukamachi K, Karimov JH. Biventricular assist devices and total artificial heart: strategies and outcomes. Front Cardiovasc Med 2023;9:972132.
Chen Q, Chan J, Akhmerov A, et al. Heart transplantation after total artificial heart bridging-outcomes over 15 years. Clin Transplant 2022;36:e14781.
Tan MC, Yeo YH, Tham JW, et al. Adverse events in total artificial heart for end-stage heart failure: insight from the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE). Int J Heart Fail 2024;6:76-81.
Moazami N, Stern JM, Khalil K, et al. Pig-to-human heart xenotransplantation in two recently deceased human recipients. Nat Med 2023;29:1989-97. https://doi.org/10.1038/s41591-023-02471-9